Alterity Therapeutics Ltd ADR (ATHE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
(Values in U.S. thousands)
06-2001 | 06-2000 | |
Sales | 510 | 70 |
Gross Profit | 510 | 70 |
Operating Expenses | 1,730 | 1,070 |
Operating Income | -1,220 | -1,000 |
Other Income | -2,910 | -320 |
Pre-tax Income | -4,130 | -1,320 |
Net Income Continuous | -4,130 | -1,320 |
Net Income | $-4,130 | $-1,320 |
EBITDA(a) | $-1,220 | $-1,000 |